Cost Savings of Expedited Care with Upfront Next-Generation Sequencing Testing versus Single-Gene Testing among Patients with Metastatic Non-Small Cell Lung Cancer Based on Current Canadian Practices

This study assessed the total costs of testing, including the estimated costs of delaying care, associated with next-generation sequencing (NGS) versus single-gene testing strategies among patients with newly diagnosed metastatic non-small cell lung cancer (mNSCLC) from a Canadian public payer persp...

Full description

Bibliographic Details

Published in:	Current Oncology
Main Authors:	Brandon S. Sheffield, Kiefer Eaton, Bruno Emond, Marie-Hélène Lafeuille, Annalise Hilts, Patrick Lefebvre, Laura Morrison, Andrea L. Stevens, Emmanuel M. Ewara, Parneet Cheema
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Subjects:	non-small cell lung cancer economic model next-generation sequencing testing costs medical costs
Online Access:	https://www.mdpi.com/1718-7729/30/2/180